Acutaas Chemicals · NSE: ACUTAAS · BSE: 543349
Q3 FY24 results · Oct–Dec 2023
Acutaas Chemicals reported revenue from operations of ₹166.44 crore (up 9.2% from Q3 FY23) and net profit of ₹17.81 crore (down 20.1% from Q3 FY23) for Q3 FY24 (Oct–Dec 2023), on a consolidated basis.
| Item | Q3 FY24 | Q3 FY23 | YoY | Q2 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 166.44 | 152.36 | +9.2% | 172.36 | −3.4% |
| Other income | 3.49 | 3.02 | +15.6% | 1.50 | +132.5% |
| Total income | 169.94 | 155.38 | +9.4% | 173.86 | −2.3% |
| Profit before tax | 23.70 | 29.57 | −19.8% | (9.94) | Turned profit |
| Net profit for the period | 17.81 | 22.28 | −20.1% | (17.02) | Turned profit |
| Attributable to shareholders of the company | 16.75 | — | — | (18.85) | Turned profit |
| EPS, basic (₹) | 4.83 | 6.28 | −23.1% | (4.67) | Turned profit |
| Net margin (%) | 10.7 | 14.6 | -9.9 |
| Item | Q3 FY24 | Q3 FY23 | YoY | Q2 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 161.70 | 152.36 | +6.1% | 163.60 | −1.2% |
| Other income | 2.87 | 3.02 | −4.9% | 1.26 | +127.9% |
| Total income | 164.57 | 155.38 | +5.9% | 164.86 | −0.2% |
| Profit before tax | 20.34 | 29.57 | −31.2% | (16.05) | Turned profit |
| Net profit for the period | 15.70 | 22.28 | −29.5% | (20.96) | Turned profit |
| EPS, basic (₹) | 4.26 | 6.12 | −30.4% | (5.75) | Turned profit |
| Net margin (%) | 9.7 | 14.6 | -12.8 |
Consolidated
- Filed with BSE
- 13 Feb 2024, 13:23 IST
- Board meeting
- 12 Feb 2024
- Period
- 01 Oct 2023 to 31 Dec 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 13 Feb 2024, 13:23 IST
- Board meeting
- 12 Feb 2024
- Period
- 01 Oct 2023 to 31 Dec 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE